NRXS: שולי רווח תפעולי NeurAxis, Inc.

NeurAxis, Inc. (NRXS) is implementing IB-Stim non-drug neurostimulation to combat pediatric abdominal pain. The operating profit margin demonstrates the effectiveness of this model, where the -186.20 level indicates the status of the parameter. Patent protection and FDA certifications create significant barriers to entry for competitors. Ultimate success depends on recognition by insurance companies and the adoption rate of the devices in medical practice.
NeurAxis - פילוחים אנליטיים ומדדי מפתח (NRXS)

NeurAxis, Inc. specializes in the high-tech assembly of electrical stimulation systems, minimizing environmental costs through the recycling of electronic components and energy conservation. The efficiency of these processes is reflected in the operating margin, which measures the share of profit from core operations in revenue before taxes and interest, allowing the chronology of the operating margin to assess the internal profitability of the business and its resilience to fiscal risks.